The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000574347p
Ethics application status
Help: Ethics application status
Not yet submitted
Date submitted
Help: Date submitted
15/04/2026
Date registered
Help: Date registered
7/05/2026
Date last updated
Help: Date last updated
7/05/2026
Date data sharing statement initially provided
Help: Data sharing statement date
7/05/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Preoperative Intervention & Management for Excess weight (PRIME): A multi-site, randomised controlled trial to evaluate the safety and acceptability of pre-surgery dietitian support versus usual care for patients with excess weight scheduled for colorectal cancer surgery
Scientific title
Preoperative Intervention & Management for Excess weight (PRIME): A multi-site, randomised controlled trial to evaluate the safety and acceptability of pre-surgery dietitian support using remotely-delivered Very Low Calorie Diet Clinic versus usual care for patients with excess weight scheduled for colorectal cancer surgery across Metro South Health.
Additional trial identifiers [1] 317038 0
Nil
Universal Trial Number (UTN)
Trial acronym
PRIME
Related trial records

Health condition
Health condition(s) studied:
Obesity 341537 0
colorectal cancer 341703 0
bowel cancer 341704 0
Condition category
Condition code
Surgery 337609 337609 0 0
Other surgery
Diet and Nutrition 337610 337610 0 0
Obesity
Cancer 337611 337611 0 0
Bowel - Back passage (rectum) or large bowel (colon)

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
The basis of the intervention is a dietitian-led very low calorie diet (VLCD) program. A Very Low Calorie Diet utilises meal replacement products (Optifast or Optislim) providing ~800kcal/day and will be individualised through dietitian-led treatment. The VLCD will include the oral consumption of 1-4 meal replacement products, with an additional 2 cups of non-starchy vegetables and at least 2 litres of non-caffeinated, calorie-free fluids. Dependent on lifestyle factors, age, and ability to adhere to the diet, participants will be recommended to consume variations of the described VLCD, utilising 1-4 meal replacement products, and specific portions of allowed foods.

At the initial dietitian appointment (60mins), education about the VLCD-based prescription will be delivered. Participants will attend weekly dietitian appointments until surgery. At review appointments (20-30 mins), the aim is to check adherence to the prescription (and provide recommendations to adjust as needed), maintain motivation during the adjustment to meal replacements, and problem-solve issues that arise. In addition to the weekly dietitian reviews, other methods of remote or digital interaction may be initiated by the participant to the dietitian, such as SMS or email. Adherence to the intervention will be assessed using diet histories taken weekly by dietitian at review appointments. Participants will also be asked questions to measure adherence within the intervention participant survey which will be administered on surgery day or as close to surgery day as possible.

The dietitian appointments will be administered via telehealth (video or phone calls) and the participants will be asked to follow the diet at home while undertaking their usual life. They will not be admitted to hospital for administration of the intervention.

The VLCD program will be delivered between 30 days and 14 days prior to surgery, depending on the participants scheduled surgery date. Durations will be recorded.
Intervention code [1] 333795 0
Lifestyle
Intervention code [2] 333901 0
Treatment: Other
Intervention code [3] 333902 0
Behaviour
Description of the comparator or control
Control group participants will follow the local standard preoperative care pathways that may include advice and support on prehabilitation. Usual care for colorectal cancer patients does not include any specific dietary intervention for weight loss, however the surgeon or surgical team may ask patient to lose weight if they determine that weight loss is clinically beneficial to the surgery. Their care will remain under standard preoperative processes, which generally involve assessment by their surgeon for booking and consenting for surgery and awaiting a surgical date with no interim intervention. They may attend appointments with relevant staff and receive pathology testing as part of usual perioperative care at the study site.

Apart from the two time-points where their measurements are taken for the study, there will be no change to usual care.
Control group
Active

Outcomes
Primary outcome [1] 345110 0
Safety
Timepoint [1] 345110 0
Baseline, pre-op and 30d post-op
Primary outcome [2] 345111 0
Acceptability
Timepoint [2] 345111 0
Baseline, pre-op and 30d post-op
Secondary outcome [1] 460512 0
Morbidity
Timepoint [1] 460512 0
At time of surgery to 30days post-op. Data collected from medical chart (no assessment necessary at 30days postop.
Secondary outcome [2] 461058 0
Resection margins
Timepoint [2] 461058 0
Data collected from medical chart notes at 30 days postop
Secondary outcome [3] 461059 0
Operation time (minutes)
Timepoint [3] 461059 0
Data collected from medical chart notes at 30 days postop
Secondary outcome [4] 461060 0
Length of hospital stay
Timepoint [4] 461060 0
Data collected from medical chart notes at 30 days postop
Secondary outcome [5] 461061 0
number of days alive and out of hospital
Timepoint [5] 461061 0
Data collected from medical chart notes at latest time point of data collection available
Secondary outcome [6] 461062 0
interoperative blood loss
Timepoint [6] 461062 0
Data collected from medical chart notes at 30 days postop
Secondary outcome [7] 461063 0
conversion to open surgery from laparoscopic
Timepoint [7] 461063 0
Data collected from medical chart notes at 30 days postop
Secondary outcome [8] 461064 0
reoperation during index hospital stay
Timepoint [8] 461064 0
Data collected from medical chart notes at 30 days postop
Secondary outcome [9] 461065 0
30-day readmission
Timepoint [9] 461065 0
data taken from medical chart at 30 days postop
Secondary outcome [10] 461066 0
reoperation between initial discharge and 20 days postop
Timepoint [10] 461066 0
data taken from medical chart at 30 days postop
Secondary outcome [11] 461067 0
anastamotic leak
Timepoint [11] 461067 0
data taken from medical chart at 30 days postop

Eligibility
Key inclusion criteria
Adults
Planned for elective curative CRC resection
BMI of 28kg/m2 or above
Completed neoadjuvant (e.g. chemotherapy / radiation) treatment (if indicated).
At least 14 days until surgery (at least 14 days on VLCD required to facilitate meaningful weight loss and liver volume reduction)
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
Unintentional loss of 10% or more body weight in last 6 months
Taking warfarin
ASA Physical Status IV
Already attending VLCD Clinic care outside of the trial
Radiological suspicion of imminent intestinal obstruction or endoscopic evidence of an impassable tumour
Pregnancy, breastfeeding, or planning pregnancy during the course of the trial
Any other significant disease or disorder which may either put the participants at risk because of participation in the trial, or may influence the result of the trial, or the participant’s ability to participate in the trial.
Currently taking part in other interventional clinical trials unless agreed in advance by all trial teams (participation in observational studies is allowed)

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
REDCap will be used for randomisation. The randomiser will enter the participant details into the REDCap Randomisation. The system will allocate the participant and instantly inform them of the allocation. They will then inform the participant of their allocation.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Simple randomisation using a randomisation table created by computer software (microsoft excel)
Masking / blinding
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
QLD
Recruitment hospital [1] 29442 0
Princess Alexandra Hospital - Woolloongabba
Recruitment hospital [2] 29443 0
Logan Hospital - Meadowbrook
Recruitment hospital [3] 29444 0
Queen Elizabeth II Jubilee Hospital - Coopers Plains
Recruitment postcode(s) [1] 45762 0
4102 - Woolloongabba
Recruitment postcode(s) [2] 45763 0
4131 - Meadowbrook
Recruitment postcode(s) [3] 45764 0
4108 - Coopers Plains

Funding & Sponsors
Funding source category [1] 321632 0
Government body
Name [1] 321632 0
Metro South Health
Country [1] 321632 0
Australia
Primary sponsor type
Government body
Name
Metro South Health
Address
Country
Australia
Secondary sponsor category [1] 324453 0
None
Name [1] 324453 0
Address [1] 324453 0
Country [1] 324453 0

Ethics approval
Ethics application status
Not yet submitted
Ethics committee name [1] 320157 0
Metro South Human Research Ethics Committee
Ethics committee address [1] 320157 0
Ethics committee country [1] 320157 0
Australia
Date submitted for ethics approval [1] 320157 0
14/05/2026
Approval date [1] 320157 0
Ethics approval number [1] 320157 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 149634 0
Dr Sally Griffin
Address 149634 0
Nutrition & Dietetics Department Logan Hospital Cnr Armstrong and Loganlea Rds Meadowbrook QLD 4131
Country 149634 0
Australia
Phone 149634 0
+61732998710
Fax 149634 0
Email 149634 0
Contact person for public queries
Name 149635 0
Sally Griffin
Address 149635 0
Nutrition & Dietetics Department Logan Hospital Cnr Armstrong and Loganlea Rds Meadowbrook QLD 4131
Country 149635 0
Australia
Phone 149635 0
+61732998710
Fax 149635 0
Email 149635 0
Contact person for scientific queries
Name 149636 0
Sally Griffin
Address 149636 0
Nutrition & Dietetics Department Logan Hospital Cnr Armstrong and Loganlea Rds Meadowbrook QLD 4131
Country 149636 0
Australia
Phone 149636 0
+61732998710
Fax 149636 0
Email 149636 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.